Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-011441-11Phase 4Terminated
Phase 4, randomised, double-blind trial in heart failure (HF) comparing Simdax with Placebo (2 arms). Primary endpoints: Incidence of admission or hospitalization for worsening or decompensation of heart failure and Time from randomization to first hospitalization for heart failure decompensation. Started Jun 2009; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-011441-11.